OOIR: Observatory of International Research

Papers

(The TQCC of Hypertension is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Age and Multimorbidity Predict Death Among COVID-19 Patients	307
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension	241
Blood Pressure and Risks of Cognitive Impairment and Dementia	189
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association	184
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension	183
May Measurement Month 2019	162
Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary	154
Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018	152
Trimethylamine-N-Oxide Promotes Age-Related Vascular Oxidative Stress and Endothelial Dysfunction in Mice and Healthy Humans	142
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor	140
Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness	135
Management of Hypertension in the Digital Era	128
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension	122
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease	112
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19	110
Early and Supernormal Vascular Aging	109
Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension	107
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension	104
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association	100
ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic	98
Discrimination and Hypertension Risk Among African Americans in the Jackson Heart Study	97
Antihypertensive Drugs and COVID-19 Risk	95
Evaluation of the Accuracy of Cuffless Blood Pressure Measurement Devices: Challenges and Proposals	95
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine	86
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association	85

Urate, Blood Pressure, and Cardiovascular Disease	84
Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Hypertension	84
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients	80
Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020	79
Microbial Peer Pressure	77
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study	75
Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk	75
Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure	73
Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease	72
Influence of Sex and Age on Muscle Sympathetic Nerve Activity of Healthy Normotensive Adults	68
Epithelial Sodium Channel and Salt-Sensitive Hypertension	68
Blood Pressure and Risk of Cardiovascular Disease in UK Biobank	67
Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association	65
Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association	65
Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis	65
Modest Sodium Reduction Increases Circulating Short-Chain Fatty Acids in Untreated Hypertensives	65
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study	65
COVID-19	64
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk	64
Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension	61
Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension	60
Visit-to-Visit Blood Pressure Variability Is Associated With Cognitive Decline and Incident Dementia	60
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination	60
Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2 , the Receptor for SARS-CoV-2 Infectivity	60
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases	59
Hypertension, Prehypertension, and Hypertension Control	59
Impact of the Vulnerable Preterm Heart and Circulation on Adult Cardiovascular Disease Risk	59
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing	58
Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses	58
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors	58
Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System	57
Neuronal Networks in Hypertension	57
Role of Klotho in the Development of Essential Hypertension	57
Mitochondrial Fission Mediates Endothelial Inflammation	57
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries	55
Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups	55
Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice	54
Heart Failure in Women With Hypertensive Disorders of Pregnancy	54
Circadian Rhythm, Clock Genes, and Hypertension: Recent Advances in Hypertension	54
Worldwide Trends in Prevalence, Mortality, and Disability-Adjusted Life Years for Hypertensive Heart Disease From 1990 to 2017	54
Aldosterone as a Mediator of Cardiovascular Damage	54
Aortic Pulse Wave Velocity Predicts Cardiovascular Events and Mortality in Patients Undergoing Coronary Angiography	54
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk	53
Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism	53
Racial Disparities in Cardiovascular Complications With Pregnancy-Induced Hypertension in the United States	53
Gut Microbiome-Derived Metabolite Trimethylamine N-Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans	53
Hypertension, Neurovascular Dysfunction, and Cognitive Impairment	53
Data Sharing Under the General Data Protection Regulation	53
Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study	52
Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium	52

Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients	52
Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling	51
Short-Term Postpartum Blood Pressure Self-Management and Long-Term Blood Pressure Control: A Randomized Controlled Trial	51
Upregulation of Piezo1 (Piezo Type Mechanosensitive Ion Channel Component 1) Enhances the Intracellular Free Calcium in Pulmonary Arterial Smooth Muscle Cells From Idiopathic Pulmonary Arterial Hypert	50
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality	49
Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease: Filling a Guidance Gap: A Scientific Statement From the American Heart Association	49
Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways: A Multisite Analysis of Ambulatory Blood Pressure	49
Dietary Approaches to Stop Hypertension Dietary Intervention Improves Blood Pressure and Vascular Health in Youth With Elevated Blood Pressure	49
Reference Intervals for Brachial Artery Flow-Mediated Dilation and the Relation With Cardiovascular Risk Factors	49
Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis	48
Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study	48
Antihypertensive Drugs and Risk of Depression	48
Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity	48
Exposure to Particulate Matter Is Associated With Elevated Blood Pressure and Incident Hypertension in Urban India	48
Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia	47
Microbiota Introduced to Germ-Free Rats Restores Vascular Contractility and Blood Pressure	47
New Concept of Onco-Hypertension and Future Perspectives	47
Butyrate Regulates COVID-19–Relevant Genes in Gut Epithelial Organoids From Normotensive Rats	47
High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients	46
Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium	46
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System	46
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success	46
Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain	45
Trends in Hypertension-Related Cardiovascular Mortality in the United States, 2000 to 2018	45
Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension	43
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories	43
Ca ²⁺ -Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production	43
Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?	43
Effects of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Overweight/Obesity and Elevated Blood Pressure/Hypertension: a Cross-Lagged Cohort Study	43
Arterial Stiffness in Aging: Does It Have a Place in Clinical Practice?	43
Trends in Worldwide Research in Hypertension Over the Period 1999–2018	43
Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension	42
Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association	42
Gut Microbiota Profile Identifies Transition From Compensated Cardiac Hypertrophy to Heart Failure in Hypertensive Rats	42
Hypertension, Arterial Stiffness, and Diabetes: a Prospective Cohort Study	41
Pediatric and Adult Ambulatory Blood Pressure Thresholds and Blood Pressure Load as Predictors of Left Ventricular Hypertrophy in Adolescents	41
Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults	41
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension	41
Digital Therapeutics in Hypertension: Evidence and Perspectives	40
Effects of Home Particulate Air Filtration on Blood Pressure	40
Developmental and Early Life Origins of Cardiometabolic Risk Factors	40
Effect of Sleep Disturbances on Blood Pressure	40
Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New Treatments	40
White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020	39
The Association of Age at Diagnosis of Hypertension With Brain Structure and Incident Dementia in the UK Biobank	39
Single-Center Prospective Cohort Study on the Histopathology, Genotype, and Postsurgical Outcomes of Patients With Primary Aldosteronism	39
Caspase-4/11–Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension	39
Brain Functional Magnetic Resonance Imaging Highlights Altered Connections and Functional Networks in Patients With Hypertension	39
Left Atrioventricular Coupling Index as a Prognostic Marker of Cardiovascular Events: The MESA Study	39
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure	39
Effect of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Dysglycemia, Insulin Resistance, and Dyslipidemia: a Temporal Causal Longitudinal Study	38
Immune System and Microvascular Remodeling in Humans	38
Genetics of Primary Aldosteronism	38
Obstructive Sleep Apnea–Induced Neurogenic Nocturnal Hypertension	37
Nitric Oxide-cGMP Signaling in Hypertension	37
Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection	36
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma	36
Retinal Vessel Diameters and Blood Pressure Progression in Children	36
Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations	36
Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality	36
Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling	35
Effect and Acceptability of Mindfulness-Based Stress Reduction Program on Patients With Elevated Blood Pressure or Hypertension	35
Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):	35
Preconception Blood Pressure and Its Change Into Early Pregnancy	35
Inverse Association Between Riboflavin Intake and New-Onset Hypertension	35
Furosemide for Accelerated Recovery of Blood Pressure Postpartum in Women with a Hypertensive Disorder of Pregnancy	35
Direct Comparison of Home Versus Ambulatory Defined Nocturnal Hypertension for Predicting Cardiovascular Events	35
Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components	35
Prediction of Cardiovascular Events by Type I Central Systolic Blood Pressure	34
Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice	34
Confounding Factors in Renal Denervation Trials	34
Isolated Diastolic Hypertension in the UK Biobank	34
Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers	34
Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension	34
Blood Pressure Classification of 2017 Associated With Cardiovascular Disease and Mortality in Young Chinese Adults	34
ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk	34
Dietary Carbohydrate Intake and New-Onset Hypertension: A Nationwide Cohort Study in China	34
Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study	34
Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control	34
Multi-Fetal Pregnancy, Preeclampsia, and Long-Term Cardiovascular Disease	33

Association Between Periodontitis and Blood Pressure Highlighted in Systemically Healthy Individuals	33
Identification, Heritability, and Relation With Gene Expression of Novel DNA Methylation Loci for Blood Pressure	33
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea	33
Origins of Primary Hypertension in Children	33
Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community	33
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines	32
Validation Study to Determine the Accuracy of Central Blood Pressure Measurement Using the Sphygmocor Xcel Cuff Device	32
Microdissection of the Human Renal Nervous System	32
PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center	31
Mid to Late Life Hypertension Trends and Cerebral Small Vessel Disease in the Framingham Heart Study	31
Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage	31
Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: The REMODEL Study	30
The 2020 “WHO Technical Specifications for Automated Non-Invasive Blood Pressure Measuring Devices With Cuff”	30
Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)	30
Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease	30
Percutaneous Intracoronary Delivery of Plasma Extracellular Vesicles Protects the Myocardium Against Ischemia-Reperfusion Injury in Canis	30
Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Adults With Hypertension	30
Precise Mapping of Intra-Adrenal Aldosterone Activities Provides a Novel Surgical Strategy for Primary Aldosteronism	30
Myeloid Piezo1 Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation	30
Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People	30
Aortic Stiffness, Central Blood Pressure, and Pulsatile Arterial Load Predict Future Thoracic Aortic Aneurysm Expansion	29
Twenty-Four–Hour Urinary Sodium and Potassium Excretion and Their Associations With Blood Pressure Among Adults in China	29
Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation	29
Clinical Applicability of Monitoring Antihypertensive Drug Levels in Blood	29
Independent Associations of Education, Intelligence, and Cognition With Hypertension and the Mediating Effects of Cardiometabolic Risk Factors: A Mendelian Randomization Study	29
Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis	29
Cellular Senescence	29
Effects of Experimental Sleep Restriction on Ambulatory and Sleep Blood Pressure in Healthy Young Adults: A Randomized Crossover Study	28
Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension	28
Pulse Pressure, Prognosis, and Influence of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction	28
Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II–Induced Hypertension in Mice	28
Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension	28
Per- and Polyfluoroalkyl Substances and Incident Hypertension in Multi-Racial/Ethnic Women: The Study of Women's Health Across the Nation	27
Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza	27
FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension	27
Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?	27
Machine Learning Clustering for Blood Pressure Variability Applied to Systolic Blood Pressure Intervention Trial (SPRINT) and the Hong Kong Community Cohort	27
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes	26
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease	26
New Noninvasive Methods to Evaluate Microvascular Structure and Function	26
Do β-Blockers Cause Depression?	26
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report	26
Inorganic Nitrite Supplementation Improves Endothelial Function With Aging	26
Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective	26
How to Improve Awareness, Treatment, and Control of Hypertension in Africa, and How to Reduce Its Consequences: A Call to Action From the World Hypertension League	26
l -Tryptophan–Induced Vasodilation Is Enhanced in Preeclampsia	25
Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis	25
Salt Sensitivity of Blood Pressure in Women	25
Neutrophil Extracellular Traps Promote the Development of Intracranial Aneurysm Rupture	25
Magnesium Supplementation Attenuates Pulmonary Hypertension via Regulation of Magnesium Transporters	25
Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loaded db/db Mice	25
NOX4/H ₂ O ₂ /mTORC1 Pathway in Salt-Induced Hypertension and Kidney Injury	25
IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice	25
Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument	25
Primary Cilia in Trophoblastic Cells	25
Early-but Not Late-Onset Hypertension Is Related to Midlife Cognitive Function	24
Hypertension Burden and the Risk of New-Onset Atrial Fibrillation	24
Association Between Hypertensive Disorders of Pregnancy and Dementia: a Systematic Review and Meta-Analysis	24
Folic Acid Supplement Use and Increased Risk of Gestational Hypertension	24
Diurnal Timing Dependent Alterations in Gut Microbial Composition Are Synchronously Linked to Salt-Sensitive Hypertension and Renal Damage	24
Estimated 24-Hour Urinary Sodium Excretion and Incident Cardiovascular Disease and Mortality Among 398 628 Individuals in UK Biobank	24
Long-Term Blood Pressure Variability and Risk of Cardiovascular Disease Events Among Community-Dwelling Elderly	24
Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy	24
Antihypertensive Treatment in Elderly Frail Patients	24
Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors	24
Blood Pressure and Angiogenic Markers in Pregnancy	24
Systolic Blood Pressure and Mortality in Community-Dwelling Older Adults: Frailty as an Effect Modifier	24
Racial and Ethnic Differences in Blood Pressure Among US Adults, 1999–2018	24
Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism	24
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria	24
Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts	24
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension	24
STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy	24
Single-Nucleus RNA Sequencing of the Hypothalamic Arcuate Nucleus of C57BL/6J Mice After Prolonged Diet-Induced Obesity	24
Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease	24
Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses	23
Historical and Recent Changes in Maternal Mortality Due to Hypertensive Disorders in the United States, 1979 to 2018	23
Proximal Tubule-Specific Deletion of Angiotensin II Type 1a Receptors in the Kidney Attenuates Circulating and Intratubular Angiotensin II–Induced Hypertension in PT- Agtr1a	23
Maternal Vascular Lesions in the Placenta Predict Vascular Impairments a Decade After Delivery	23
Uric Acid Expression in Carotid Atherosclerotic Plaque and Serum Uric Acid Are Associated With Cerebrovascular Events	23
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue	23
Longitudinal Changes of Input Impedance, Pulse Wave Velocity, and Wave Reflection in a Middle-Aged Population	23
Cardiovascular Health Profile at Age 25 Years in Adults Born Extremely Preterm or Extremely Low Birthweight	23
Maternal Hypertension Increases Risk of Preeclampsia and Low Fetal Birthweight: Genetic Evidence From a Mendelian Randomization Study	23
Immune Mechanisms of Dietary Salt-Induced Hypertension and Kidney Disease: Harry Goldblatt Award for Early Career Investigators 2020	23
Occupational Physical Activity and New-Onset Hypertension: A Nationwide Cohort Study in China	23
Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy	23
Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model	23
Total Versus Free Placental Growth Factor Levels in the Pathogenesis of Preeclampsia	23
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction	23
Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling	23
Effect of Antihypertensive Treatment on Cerebral Blood Flow in Older Adults: a Systematic Review and Meta-Analysis	23
Usefulness of the sFlt-1/PlGF (Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia	23
Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure	23
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients	23